Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,160,793
-$2,863,634 QoQ
Shares Held
17,103
-52.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#807
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. GILD ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,160,793 | 17,103 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,024,427 | 36,051 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,485,202 | 28,395 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $3,352,644 | 30,204 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,936,170 | 26,483 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,571,211 | 22,947 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,169,584 | 34,314 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,038,696 | 36,244 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $2,266,188 | 33,030 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,507,494 | 34,232 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,452,739 | 30,277 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,174,309 | 29,014 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,335,314 | 17,326 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $836,337 | 10,080 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,378,665 | 16,059 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,113,010 | 18,042 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,047,988 | 16,955 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,067,424 | 17,955 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,665,310 | 22,935 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,517,561 | 21,726 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $936,220 | 13,596 | Shares | Sole | 2021-07-22 | |
| 2020-09-30 | $210,043 | 3,324 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $268,135 | 3,485 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $175,910 | 2,353 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||